中国癌症杂志 ›› 2017, Vol. 27 ›› Issue (3): 227-232.doi: 10.19401/j.cnki.1007-3639.2017.03.011

• 论著 • 上一篇    下一篇

腺癌与其他类型非小细胞肺癌术后临床特点的差异及预后因素分析

田希贵,刘德森,汪元玉,王 超   

  1. 广西医科大学附属肿瘤医院胸外科,广西 南宁530021
  • 出版日期:2017-03-30 发布日期:2017-04-12
  • 通信作者: 刘德森 E-mail:desenliu57@qq.com
  • 基金资助:
    广西医疗卫生重点科研课题(重200966)。

Postoperative differences in clinical characteristics between adenocarcinoma and other types of nonsmall cell lung cancer and analysis of prognostic factors of adenocarcinoma treated with surgery

TIAN Xigui, LIU Desen, WANG Yuanyu, WANG Chao   

  1. Department of Thoracic Surgery, Affiliated Tumor Hospital of Guangxi Medical University, Nanning 530021, Guangxi Zhuang Autonomous Region, China
  • Published:2017-03-30 Online:2017-04-12
  • Contact: LIU Desen E-mail: desenliu57@qq.com

摘要: 背景与目的:近年来肺腺癌已成为肺癌最常见的病理类型,且呈逐年上升的趋势。该研究探讨肺腺癌与其他类型非小细胞肺癌(non-small cell lung cancer,NSCLC)术后临床特点的差异及影响其术后预后的因素。方法:选取广西医科大学附属肿瘤医院2005年1月1日—2014年12月31日经手术治疗的NSCLC患者的病历资料,比较腺癌与其他类型癌临床特点的差异,并运用log-rank方法及Cox比例风险回归模型分析影响腺癌术后预后的因素。结果:451例腺癌患者中,男性与女性比例为1.29∶1,平均发病年龄为56.02岁,淋巴结转移率为53.22%(240/451),中位生存期为44个月;其与其他类型NSCLC在性别比例(P<0.001)、平均发病年龄(P=0.039)、淋巴结转移率(P=0.012)和中位生存期(P<0.001)方面差异均有统计学意义。多因素分析显示:PTNM分期(P<0.001)、性别(P=0.032)、术前合并糖尿病(P=0.019)、隆突下淋巴结转移(P=0.013)、淋巴结转移组数(P<0.001)、术后化疗(P=0.040)或靶向治疗(P<0.001)是影响腺癌术后预后的独立因素。结论:与其他类型NSCLC相比,腺癌具有女性发病率高、平均发病年龄较低、淋巴结转移率较高和预后较差的特点;PTNM分期、性别、术前合并糖尿病、隆突下淋巴结转移、淋巴结转移组数、术后化疗或靶向治疗是影响其术后预后的重要因素,可为评估预后提供参考。

关键词: 肺腺癌, 临床特点, 手术治疗, 预后

Abstract: Background and purpose: Adenocarcinoma has become the most common histological type of lung cancer in recent years, and there is an increasing trend. This study aimed to investigate postoperative differences in clinical characteristics between adenocarcinoma and other types of non-small cell lung cancer (NSCLC) and prognostic factors of adenocarcinoma treated with surgery, and to provide a reference for the prevention and treatment of lung adenocarcinoma. Methods: The medical records of patients with NSCLC treated with surgery were selected from Jan. 2005 to Dec. 2014 at the Affiliated Tumor Hospital of Guangxi Medical University. This study compared the differences in clinical characteristics between adenocarcinoma and other types of NSCLC, and analyzed the influence of prognostic factors of lung adenocarcinoma with log-rank test and COX model. Results: With 451 cases of adenocarcinoma, the gender ratio was 1.29∶1, the average age was 56.02 years old, the lymph node metastasis rate was 53.22% (240/451), and the median survival time was 44 months. There were statistical differences between adenocarcinoma and other types of NSCLC in gender ratio (P<0.001), average age (P=0.039), lymph node metastasis rate (P=0.012), and median survival time (P<0.001). In multivariate analysis, PTNM stage (P<0.001), gender (P=0.032), preoperative diabetes (P=0.019), subcarinal lymph node metastasis (P=0.013), number of lymph node metastasis (P<0.001), postoperative chemotherapy (P=0.040) or targeted therapy after surgery (P<0.001) were independent prognostic factors. Conclusion: Compared with other types of NSCLC, adenocarcinoma showed the characteristics of higher incidence of constituent ratio in women, lower average age, higher rate of lymph node metastasis and poor prognosis. PTNM stage, gender, preoperative diabetes, subcarinal lymph node metastasis, number of lymph node metastasis, postoperative chemotherapy or targeted therapy are important influencing factors that can affect the prognosis of adenocarcinoma following the surgical procedure.

Key words: Lung adenocarcinoma, Clinical characteristics, Surgical procedure, Prognosis